Lydia Scarfò

Also affiliated with IRCCS Ospedale San Raffaele

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial”.

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00396-6

N/A

0.903DataRank · unranked

34 citations

Anna Maria Frustaci, Adalgisa Condoluci, Marta Coscia, Roberto Chiarle, Pier Luigi Zinzani +19 more

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

Leukemia(2025)10.1038/s41375-025-02662-y

N/A

0DataRank · unranked

18 citations

Thomas Chatzikonstantinou, Marina Gerousi, Richard Rosenquist, Gianluca Gaïdano, Šárka Pospı́šilová +12 more